Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors
Cell Reports · 2026-03 · 45 (3) · 117035
DOI: 10.1016/j.celrep.2026.117035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-03. Verfasst von Yi Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Institute of Materials Science & Engineerin…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Interleukins, Histocompatibility Antigens Class I, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Massachusetts Institute of Technology, China Scholarship Council, European Research Council.
Abstract (Originalsprache)
Natural killer (NK) cells, a type of potent cytotoxic lymphocyte, are particularly promising for the treatment of cancers that lose or downregulate major histocompatibility complex class I (MHC class I) expression to evade T cell-mediated immunotherapy. However, the hostile and immunosuppressive tumor microenvironment (TME) greatly hinders the function of tumor-infiltrating NK cells, thus limiting the therapeutic efficacy. Here, we show a fusion protein of interleukin 21 (IL-21-Fc) that safely and effectively reprograms NK cell metabolism and restores their effector function in vivo . IL-21-Fc synergizes with IL-15 superagonist (IL-15SA) or adoptive NK cell transfer to eradicate MHC class I-deficient tumors and confer durable protection across multiple murine models. Mechanistically, we uncover that IL-21-Fc enhances NK cell effector function by upregulating glycolysis in a lactate dehydrogenase A (LDHA)-dependent manner. This study reveals LDHA-dependent metabolic reprogramming as a key axis for NK cell rejuvenation and positions IL-21-Fc as a promising, clinically translatable strategy to overcome TME-mediated suppression in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; Institute of Materials Science & Engineering, EPFL, 1015 Lausanne, Switzerland.
- State Key Laboratory of Immune Response and Immunotherapy, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of University of Science and Technology of China (USTC), Universi…
- Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang…
- Department of Oncology, University of Lausanne, 1011 Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
- Institute of Materials Science & Engineering, EPFL, 1015 Lausanne, Switzerland.
- Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Förderung
- Massachusetts Institute of Technology
- China Scholarship Council
- European Research Council
- Zhejiang Province Natural Science Foundation
- National Key Research and Development Program of China
- Chinese Academy of Sciences
- Cancer Research Foundation Switzerland
- University of California Berkeley
Zitieren
APA
Wang, Y., Huang, C., Cai, G., Andreatta, M., Kurum, A., Zhao, Y., Feng, B., Gao, M., Carmona, S. J., Zhou, Z., Sun, C., Guo, Y., & Tang, L. (2026). Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors. Cell Reports, 45(3), 117035. https://doi.org/10.1016/j.celrep.2026.117035
Vancouver
Wang Y, Huang C, Cai G, Andreatta M, Kurum A, Zhao Y, et al. Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors. Cell Reports. 2026;45(3):117035. doi:10.1016/j.celrep.2026.117035
BibTeX
@article{Wang2026,
author = {Wang, Yi and Huang, Chao and Cai, Guoxin and Andreatta, Massimo and Kurum, Armand and Zhao, Yang and Feng, Bing and Gao, Min and Carmona, Santiago J and Zhou, Zhan and Sun, Cheng and Guo, Yugang and Tang, Li},
title = {Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {3},
pages = {117035},
doi = {10.1016/j.celrep.2026.117035}
}
EUVIMED